Please Share:: 
INITIAL PUBLIC OFFER (IPO)
SHARDA CROPCHEM LIMITED
ISSUE PERIOD: SEPTEMBER 05 - SEPTEMBER 09, 2014
|
Sharda Cropchem Limited has proposed to sell 2,25,55,124 Equity Shares exclusively through Initial Public Offer (IPO) between September 05-September 09, 2014.
| Company Name | Sharda Cropchem Limited |
| Issue Period |
September 05 - Sepember 09, 2014
|
| Price Band | Rs 145/- – Rs 156/- per equity share |
| Lot Size | 90 shares & in multiple of 90 shares thereafter |
| Issue Size | INR 351.85 crs (at INR 156 per share) |
| Face Value | Rs. 10 each. |
| Listing | To be listed on NSE & BSE |
| Who Can Invest | Resident Indian individuals, HUF, Companies, corporate bodies, scientific institutions, societies and trusts, NRIs, FIIs |
|
Highlights of the Company
Sharda Cropchem Limited was incorporated as Sharda Worldwide Exports Private Limited on March 12, 2004 as a private limited company. Company was converted into a public limited company on September 18, 2013
Sharda Cropchem Limited is a crop protection chemical company engaged in the marketing and distribution of a wide range of formulations and generic active ingredients globally. It is also involved in order based procurement and supply of Belts, general chemicals, dyes and dye intermediates.
Company recently entered into the biocide segment and have acquired several registrations from the existing registration holders, primarily, in Europe.
Company has diversified range of formulations and generic active ingredients in fungicide, herbicide and insecticide segments for protecting different kind of crops as well as serve turf and specialty markets and in biocide segment as disinfectants, thereby catering to varied market demand
Company Profile
Net Profits after tax: INR 1069.03 million as on 31st March 2014
Total Income: INR 8,147.39 million as on 31st March 2014
Net worth: INR 5,528.96 million as on 31st March 2014.
|
|
��
India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details ��
��
-->
No comments:
Post a Comment